These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31100828)

  • 61. [Pathobiology of acute myeloid leukemia].
    Christ O; Feuring-Buske M; Hiddemann W; Buske C
    Med Klin (Munich); 2007 Apr; 102(4):290-5. PubMed ID: 17426932
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Role for phospholipid acyl chains and cholesterol in pulmonary infections and inflammation.
    Shaikh SR; Fessler MB; Gowdy KM
    J Leukoc Biol; 2016 Nov; 100(5):985-997. PubMed ID: 27286794
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
    Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
    J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunotherapeutic strategies for relapse control in acute myeloid leukemia.
    Martner A; Thorén FB; Aurelius J; Hellstrand K
    Blood Rev; 2013 Sep; 27(5):209-16. PubMed ID: 23871358
    [TBL] [Abstract][Full Text] [Related]  

  • 65. TNF-alpha targeted therapeutic approaches in patients with hematologic malignancies.
    Tsimberidou AM; Giles FJ
    Expert Rev Anticancer Ther; 2002 Jun; 2(3):277-86. PubMed ID: 12113051
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The essential fatty acids omega-6 and omega-3: from their discovery to their use in therapy].
    Caramia G
    Minerva Pediatr; 2008 Apr; 60(2):219-33. PubMed ID: 18449139
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Omega-6 and omega-3 polyunsaturated fatty acids and allergic diseases in infancy and childhood.
    Miles EA; Calder PC
    Curr Pharm Des; 2014; 20(6):946-53. PubMed ID: 23701554
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Up-regulation of regulatory T cells, CD200 and TIM3 expression in cytogenetically normal acute myeloid leukemia.
    Zahran AM; Mohammed Saleh MF; Sayed MM; Rayan A; Ali AM; Hetta HF
    Cancer Biomark; 2018; 22(3):587-595. PubMed ID: 29843224
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Anti-Tumor and Immune Enhancing Activities of Rice Bran Gramisterol on Acute Myelogenous Leukemia.
    Somintara S; Leardkamolkarn V; Suttiarporn P; Mahatheeranont S
    PLoS One; 2016; 11(1):e0146869. PubMed ID: 26752299
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Harnessing the immune system in acute myeloid leukaemia.
    Austin R; Smyth MJ; Lane SW
    Crit Rev Oncol Hematol; 2016 Jul; 103():62-77. PubMed ID: 27247119
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Polyunsaturated fatty acids: anticonvulsive effects and underlying mechanisms].
    Porta N; Auvin S
    Med Sci (Paris); 2009 Jan; 25(1):51-6. PubMed ID: 19154694
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Omega-3 poly-unsaturated fatty acids for the prevention of severe neutropenic enterocolitis in patients with acute myeloid leukemia.
    Bükki J; Stanga Z; Tellez FB; Duclos K; Kolev M; Krähenmann P; Pabst T; Iff S; Jüni P
    Nutr Cancer; 2013; 65(6):834-42. PubMed ID: 23909727
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dietary long-chain polyunsaturated fatty acids influence the recovery of thioacetamide-induced liver cirrhosis in rats.
    Moreira E; Fontana L; Torres MI; Fernández I; Ríos A; Sánchez de Medina F; Gil A
    JPEN J Parenter Enteral Nutr; 1995; 19(6):461-9. PubMed ID: 8748360
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Paving the Way for Immunotherapy in Pediatric Acute Myeloid Leukemia: Current Knowledge and the Way Forward.
    Koedijk JB; van der Werf I; Calkoen FG; Nierkens S; Kaspers GJL; Zwaan CM; Heidenreich O
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503174
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An Overview on Lipid Droplets Accumulation as Novel Target for Acute Myeloid Leukemia Therapy.
    Nisticò C; Chiarella E
    Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137407
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Will deeper characterization of the landscape of immune checkpoint molecules in acute myeloid leukemia bone marrow lead to improved therapeutic targeting?
    Vandsemb EN; Kim TK; Zeidan AM
    Cancer; 2019 May; 125(9):1410-1413. PubMed ID: 30861094
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dietary control of chronic headache: involvement of pro-resolution lipid mediators.
    Van De Ven T; Ji RR
    Pain; 2013 Nov; 154(11):2247-2248. PubMed ID: 23954765
    [No Abstract]   [Full Text] [Related]  

  • 78. The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies.
    Soltani M; Zhao Y; Xia Z; Ganjalikhani Hakemi M; Bazhin AV
    Front Oncol; 2021; 11():767026. PubMed ID: 34868994
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Hematologic Malignancies/Pediatric Malignancies Molecular Targeted Therapies for Acute Myeloid Leukemia].
    Yano S
    Gan To Kagaku Ryoho; 2022 May; 49(5):534-535. PubMed ID: 35578928
    [No Abstract]   [Full Text] [Related]  

  • 80. Old Dog, New Trick: Type I IFN-Based Treatment for Acute Myeloid Leukemia.
    Alsufyani A; Alanazi R; Woolley JF; Dahal LN
    Mol Cancer Res; 2021 May; 19(5):753-756. PubMed ID: 33500358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.